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Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide
Peptidase (SPP) Is Required for Virus Infectivity
Sariah J. Allen1, Kevin R. Mott1, Yoshiharu Matsuura2, Kohji Moriishi3, Konstantin G. Kousoulas4,
Homayon Ghiasi1*
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of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan, 3 Department of Microbiology, Faculty of Medicine Yamanashi University,
Yamanashi, Japan, 4 Division of Biotechnology and Molecular Medicine, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, United States of
America

Abstract
Glycoprotein K (gK) is a virion envelope protein of herpes simplex virus types 1 (HSV-1) and 2 (HSV-2), which plays important
roles in virion entry, morphogenesis and egress. Two-hybrid and pull-down assays were utilized to demonstrate that gK and
no other HSV-1 genes specifically binds to signal peptide peptidase (SPP), also known as minor histocompatibility antigen
H13. SPP dominant negative mutants, shRNA against SPP significantly reduced HSV-1 replication in vitro. SPP also affected
lysosomes and ER responses to HSV-1 infection. Thus, in this study we have shown for the first time that gK, despite its role
in fusion and egress, is also involved in binding the cytoplasmic protein SPP. These results also suggest that SPP plays an
important role in viral replication and possibly virus pathogenesis. This makes SPP unique in that its function appears to be
required by the virus as no other protein can compensate its loss in terms of viral replication.
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addition to necrotizing HSK, ocular infection with HSV-1 can
cause eye disease ranging in severity from blepharitis, conjunctivitis, and dendritic keratitis, to disciform stromal edema
[22,23,25–28]. In the U.S. approximately 500,000 people suffer
recurrent ocular HSV episodes annually, requiring doctor visits,
medication and corneal transplants in severe cases. Although the
HSV-1 gene(s) which are involved in eye disease are presently
unknown, we have demonstrated previously that immunization of
mice with glycoprotein K (gK), but not with any other known
HSV-1 glycoprotein, significantly exacerbates CS and facial
dermatitis following ocular HSV-1 infection [29–32]. This
exacerbation of CS occurs independently of both the virus strain
used for infection and the strain of mouse studied [31]. gK is
encoded by the UL53 open reading frame and is a highly
hydrophobic 338-amino-acid protein with a predicted molecular
mass of 37-kDa [32–34]. Both gK from HSV-1 and HSV-2 are
338 amino acids long with approximately 84% amino acid
homology [33,35,36]. Genome wide screenings in both HSV-1
[37] and HSV-2 [38] have shown that gK elicited CD8+ IFN-c
responses in mice and humans, respectively.
gK is an essential HSV-1 gene [32–34,39] and single amino
acid changes within gK cause extensive virus-induced cell fusion
[40–43]. Furthermore, gK is an important determinant of
cytoplasmic virion envelopment, since viruses lacking gK fail to
efficiently acquire a cytoplasmic envelope resulting in a drastic
defect in virion morphogenesis, egress and spread [44–47].
Deletion of gK results in the formation of extremely rare
microscopic plaques indicating that gK is required for efficient

Introduction
Signal peptide peptidase (SPP), also known as minor histocompatibility antigen H13, is an aspartyl protease member of the
intramembrane cleaving proteases family (I-CLiP), which specializes in the cleavage of signal peptides after their release by signal
peptidase (SP) [1,2]. SPP and SPP-like (SPPL) proteins are
evolutionarily conserved in H. sapiens, Rattus norvegicus, Oryza sativa
japonica, B. subtilis, Gallus gallus, B. taurus, X. laevis, Macaca mulatta, D.
rerio, D. melanogaster, C. elegans, S. pombe, A. thaliana, P. falciparum [3–
6] and there exists a 96% amino acid homology between human
and mouse SPP [7]. SPP localizes predominantly to the
endoplasmic reticulum (ER) and can exist in different forms
depending on glycosylation status [8]. Unlike other family
members, SPP appears to achieve enzyme activity in the absence
of protein cofactors [1,9,10]. SPP has been shown to play
important roles in extracellular and intracellular signaling events
such as cellular surveillance in MHC-I signal peptide processing
[2] and has been linked to pathogenic conditions such as
Alzheimer’s disease [11], certain cancers [12], and human
cytomegalovirus, pestivirus, malaria and Hepatitis C infections
[13–17].
HSV-1 infections are among the most frequent serious viral eye
infections in the U.S. and are a major cause of viral-induced
blindness [18–22]. HSV-1-induced corneal scarring (CS), also
broadly referred to as herpes stromal keratitis (HSK), can lead to
blindness; thus, HSV-1 is the leading cause of corneal blindness
due to an infectious agent in developed countries [21,23,24]. In
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virus replication [44,45,47,48], a concept that is supported by the
observation that gK-deficient virus can only be propagated on
complementing cells that express gK [44,45]. As gK is essential to
HSV-1 infectivity, we had previously analyzed its contribution to
CS using recombinant viruses (rather than deleting the gK gene)
with two extra copies of gK and found that similar to gK
immunization, this recombinant virus caused elevated levels of CS
in both mice and rabbits [49]. We have also shown that an
elevation of anti-gK antibody in individuals with a history of HSV1 recurrence is correlated with increased severity of eye disease
[50].
In this study we show for the first time that: 1) HSV-1 gK binds
to SPP and 2) SPP is required for virus infectivity. Despite the
seriousness of ocular herpes infection, no drug has been FDA
approved for prevention of ocular recurrences. Thus, blocking
SPP activity or binding to viral glycoproteins (such as gK) by
targeted therapeutics may represent a clinically effective and
expedient approach to the reduction of viral replication and the
resulting pathology.

Construction and expression of c-myc-gK and HA-SPP
The gK and SPP constructs used in this study are shown in
Figures S2 and S3, respectively. In Figure S2, a schematic
diagram of full-length gK with an in-frame c-myc tag at the
carboxy terminus is shown. Figure S3 shows a schematic diagram
of full-length SPP with an in-frame HA tag and ER retention
signal also located at the carboxy terminus as we described
previously [16]. gK with c-myc tag was synthesized (GenScript,
Piscataway, NJ) and inserted into BamHI site of pcDNA3.1 and
sequences were verified with standard dideoxy sequencing at the
UCLA Genotyping and Sequencing core. Amaxa nucleofactor kit
R (Lonza, Allendale, NJ) was used to transfect 106 HeLa or Vero
cells with plasmid DNA cocktail containing both HA-SPP and cmyc-gK in a ratio of 1:1 in accordance with manufacturer
instruction. Protein expression was monitored over 5 days using
Coomassie blue protein staining and Western blotting. Antibodies
against HA and c-myc (GenScript), were diluted according to
manufacturer instruction in the total Western HRP kit (GenScript). Optimum c-myc-gK and HA-SPP expression and recovery
was determined to be 48–72 hr post-transfection.

Materials and Methods

Construction and expression of SPP shRNA constructs

Cells and viruses

shRNAs against SPP were created using the Knockout single
vector inducible RNAi system (Clontech, Mountain View, CA).
Briefly, SPP siRNA oligonucleotides were designed using siRNAdesigner (www.clontech.com). The shRNAs chosen correspond to
SPP nucleotide locations 409–430 (#5/6); 644–666 (#11/12);
1134–1157 (#19/20) and a scramble of #11/12. The four
shRNA were synthesized and ligated into pSingle-tTS-shRNA
(Invitrogen) via XhoI and MluI restriction sites and the sequence
was verified using standard dideoxy sequencing. RS cells were
grown to 70% confluency on Lab-Tex chamber slides (BD Falcon,
San Jose, CA) and transfected with either SPP shRNA or scramble
shRNA using Lipofectamine-2000 (Invitrogen, Carlsbad, CA) for
8 hr followed by addition of plasmid inducer doxycycline for 12 hr
prior to HSV-1 infection according to manufacturer instruction.
Cells were infected with 0.1 PFU of HSV-1 strain McKrae for 1 hr
at 37uC, virus was then removed with three 1X PBS washes and
normal growth media + shRNA inducer replaced for 2, 4, 6, 8, 20
or 40 hr post-infection (PI). At each time point virus titer was
measured via standard plaque assay on RS cells as we described
previously [31]. Briefly, 100 mL aliquots of 10-fold serial dilutions
were placed on confluent monolayers of RS cells in 24-well plates,
incubated at 37uC for 1 hr and overlaid with medium containing
1% methylcellulose. The plates were incubated at 37uC for 3 days
and stained with 1% crystal violet, and the viral plaques were
counted.

Vero and HeLa cells were obtained from American type culture
collection (ATCC). RS (rabbit skin) cells (from Steven L Wechsler)
was described previously [51]. HeLa and Vero cells were grown in
DMEM media plus 10% fetal bovine serum (FBS), while RS cells
were grown in MEM media plus 5% FBS, while. Triple plaquepurified HSV-1 strain McKrae was grown in RS cell monolayers
as described previously [32]. V5-tagged gK recombinant viruses in
KOS background (gKV5DI, gKV5DII, gKV5DIII, and
gKV5DIV) were grown as described previously [52].

Two hybrid system
We performed a bacterial two-hybrid using the BacterioMatch
Two-Hybrid System (Stratagene, La Jolla, CA) and a mouse brain
plasmid cDNA library (Stratagene). The bait plasmid pBT
expressing a l repressor (lcI)-fused gK protein and the target
plasmid pTRG expressing the a-subunit of RNA polymerase fused
to cDNA library-encoded proteins were used in the study. We used
an E.coli reporter strain containing the two reporter genes LacZ
and Carbenecillin-resistance (Carbr) under the control of the lcI/
a-subunit of RNA polymerase. Additionally, the pBT plasmid, the
pTRG plasmid and the E.coli reporter strain contained the
chloroamphenicol (Camr), tetracycline (Tetr) and kanamycin
(Kanr) resistance genes, respectively. To construct the pBT-gK,
a cDNA encoding gK was amplified by polymerase chain reaction
(PCR) using specific primers containing EcoRI/XhoI sites and
inserted into the corresponding sites in the pBT bait plasmid. The
mouse brain cDNA library was amplified, harvested and final
plasmid DNA (pTRG-cDNA mouse brain library) purification
conducted according to manufacturer’s protocol. The E.coli
reporter strain was transformed with pBT-gK and cDNA library
cloned into pTRG and transformants were selected on Carb +
Cam + Tet + Kan supplemented LB-Agar plates. The putative
positive colonies were further tested for Lac Z activity by replica
plating these clones onto X-gal indicator plates (Cam + Tet + Kan
+X-gal + b-galactosidase inhibitor LB-Agar) followed by screening
for the blue color indicative of Lac Z expression. The mouse brain
library plasmids were recovered from the positive colonies and the
inserted target cDNA was sequenced using pTRG plasmid-specific
primers as described in the manufacture’s protocols. NCBIBLAST analysis [53] was performed on collected sequences and
putative genes identified (Figure S1).
PLOS ONE | www.plosone.org

Construction and expression of SPP dominant negative
mutants
We previously constructed two mutant forms of SPP in which
enzymatically critical Asparagine residues were mutated to
Alanine at positions 219 (D219A) and 265 (D265A) [16]. These
dominant negatives are also HA tagged with ER-retention signals
at the carboxy terminus in pcDNA3.1 vector as shown in
Figure S3 and as we described previously [16]. RS cells were
grown to confluency in Lab-Tex chamber slides and transfected
with SPP-HA, D219A-HA or D265A-HA plasmids using
Lipofectamine-2000 (Invitrogen). Transfection was allowed to
proceed for 24 hr followed by infection with 0.1 PFU of HSV-1
strain McKrae as described above. Cells were grown for 12, 24 or
48 hr PI and HSV-1 titer measured by standard plaque assay on
RS cells as described above.
2
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ally, all cellular amplicons included an intron-exon junction to
eliminate signal from genomic DNA contamination. The assays
used in this study were as follows: 1) gB specific primers (forward,
59-AACGCGACGCACATCAAG-39;
Reverse
59CTGGTACGCGATCAGAAAGC-39; and Probe - 59-FAMCAGCCGCAGTACTACC-39). Amplicon Length = 72 bp; 2)
ICP0
specific
primers
(forward,
59CGGACACGGAACTGTTCGA-39; reverse, 59-CGCCCCCGCAACTG-39;
and probe, 59-FAM-CCCCATCCACGCCCTG-39). Amplicon
length = 111 bp; 3) TK specific primers (forward, 59- CAGTAGCGTGGGCATTTTCTG-39;
reverse
primer,
59CCTCGCCGGCAACAAAA-39;
and
probe,
59-FAMCTCCAGGCGGACTTC-39). Amplicon length = 59 bp; and 4)
gK specific primers (forward, 59-GGCCACCTACCTCTTGAACTAC-39;
reverse
primer,
59-CAGGCGGGTAATTTTCGTGTAG-39; and probe, 59-FAM-CAGGCCGCATCGTATC-39). Amplicon length = 82 bp. As an internal
control, a set of GAPDH primers from Applied Biosystems
(ASSAY I.D. m999999.15_G1 – Amplicon Length = 107 bp) was
used.
In some experiments the relative copy numbers for ICP-0, gB,
and gK expressions were calculated using standard curves
generated from the plasmids pGem-ICP0, pAc-gB1, and pACgK1, while in other experiments of ICP-0, tk, gB, and gK
expressions were normalized to the levels present 1 hr after virus is
first added to the cell monolayer (the adsorption period), a time is
routinely taken as t = 0. In all experiments, GAPDH was used for
normalization of transcripts. qRT-PCR was performed using an
ABI ViiA7 sequence detection system (Applied Biosystems) in 384well plates. The threshold cycle (CT) values, which represent the
PCR cycles at which there is a noticeable increase in the reporter
fluorescence above baseline, were determined using ViiA7 RUO
software.

Immuoprecipitation (IP)
HeLa or Vero cells were transfected with c-myc-gK and HASPP as described above and were harvested at 48 hr posttransfection. Cells were lysed with lysis buffer included in the
Classic IP Kit (Pierce, Rockford, IL) and 600 mg cellular extract
was incubated with Dynabeads-G (Invitrogen) which were prebound to either HA, c-myc, irrelevant His-antibody (Invitrogen) or
SPP (Abcam) antibody. Incubation proceeded for 1 hr at RT and
beads were washed 5X with lysis buffer followed by kit-supplied
elution buffer and finally SDS-PAGE analysis and Western
blotting using the reverse antibodies that was used for IP.

Colocalization and virus detection by
immunocytochemistry (ICC)
HeLa, Vero and RS cells were grown to confluency on Lab-tek
chamber slides and infected with gK-V5-DII recombinant HSV-1
for 24 hr as we described previously [52]. Infected cells were fixed
with 4% paraformaldehyde for 1 hr at 4uC followed by
20 minutes incubation in serum free protein block (Dako,
Carpentaria, CA) at room temperature. Rabbit anti-SPP (Abcam)
was diluted according to manufacturer instructions and incubated
on slides overnight at 4uC. Slides were then washed and incubated
with anti-V5-FITC, anti-FITC Alexa Fluor 488 and anti-rabbit
Alexa Fluor 594 (Invitrogen) for 1 hr at RT. Washed slides were
air dried and mounted with 49,6-diamidino-2-phenylindole (DAPI)
prolong Gold (Invitrogen). The fluorophores were imaged in
separate channels with a Zeiss ApoTome-equipped Axio Imager
Z1 (Carl Zeiss Microimaging). For anti-HSV-1-gC-FITC staining,
RS or Vero cells were grown to confluency on chamber slides and
transfected with shRNA construct or dominative negative
construct as described above, followed by infection with 0.1
PFU/cell of McKrae for 24 hr. Fixative, blocking and mounting
was the same as above except with anti-HSV-1-gC-FITC antibody
incubation at a 1:100 dilution overnight at 4uC (Genway, San
Diego, CA). For organelle straining, RS cells were grown to
confluency on chamber slides and transfected with shRNA as
described above followed by infection with 0.1 PFU/cell of
McKrae for 24 hr. Fixative, blocking and mounting was the same
as above except with rabbit polyclonal antibodies (Abcam) against
LAMP (ab24170), EEA1 (ab2900) or Calnexin (ab22595) diluted
according to manufacturer instruction followed by anti-rabbit
Alexa Fluor 594 secondary antibody at 1:200 dilution.

Results
HSV-1 gK binds to SPP
We hypothesized that gK might exert its previously demonstrated pathogenic functions via interactions with one or more
cellular proteins. Briefly, we performed a two-hybrid screening
assay using the BacterioMatch Two-Hybrid System (Stratagene,
San Diego, CA). In this assay, gK was used as a bait to probe a
mouse brain cDNA library to find cellular proteins that interact
with gK. A total of 16106 independent cDNA clones were
screened and upon sequencing we observed a significant homology
to all isoforms of SSP (Fig. S1) suggesting a possible interaction of
gK and SPP.
To confirm the bacterial two-hybrid result of gK binding to
SPP, we first used a pull-down approach. Cellular extracts from
HeLa cells transiently expressing HA-SPP, c-myc-gK or both
plasmids were immunoprecipitated using protein G beads bound
to either anti-myc, anti-HA, or the irrelevant anti-His antibody.
Immunoprecipitates were subjected to Western analysis to detect
c-myc-gK (using c-myc Ab) or HA-SPP (using HA Ab). We
created the tagged myc-gK plasmid as there is no commercially
available antibody against gK. Furthermore, we have previously
failed in attempts to make antibody against either full-length gK or
gK peptide fragments in multiple hosts (mouse, rabbit and
chicken). Figure 1A demonstrates pull-down of HA-SPP by antiHA antibody, while Figure 1B demonstrates pull-down of c-mycgK by anti-c-myc antibody demonstrating that both proteins can
be individually immunoprecipitated using this system. Figures 1C
and 1D demonstrate successful co-immunoprecipitation of HASPP and c-myc-gK in two cell lines. Figure 1C shows gK-SPP

Fluorescent-activated cell sorting (FACS)
RS cells were transfected with SPP shRNA 11/12 as above
followed by infection with 0.1 PFU/cell of HSV-1 strain McKrae
for 24 hr or mock-infected. Infected or mock-infected cells were
harvested via centrifugation and stained with annexin-V PE mAb
(eBioscience, San Diego, CA). Stained cells were washed 2X with
FACS buffer (1X PBS with 0.1% sodium azide), resuspended in
4% paraformaldehyde, and analyzed using a multicolor five-laser
LSR II instrument (Applied Biosystems, Foster City, CA).

Gene expression analyses
qRT-PCR was performed as follows: at various times post
infection, total RNA was extracted, and 1,000 ng of total RNA
was reverse transcribed as we have described previously [54]. The
differences in the expression levels of mRNAs were evaluated
using custom-made TaqMan gene expression primers against
ICP0, tK, gB and gK with optimized primer and probe
concentrations (Applied Biosystems). Primer probe sets consisted
of two unlabeled PCR primers and the FAMTM dye-labeled
TaqMan MGB probe formulated into a single mixture. AdditionPLOS ONE | www.plosone.org
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interaction via both pull-down of c-myc-gK by anti-HA immunoprecipitation and pull-down of HA-SPP by anti-c-myc immunoprecipitation in HeLa cells. Neither HA-SPP nor c-myc-gK were
pulled down in untransfected HeLa cells (lane 1 in each figure), or
by irrelevant His-antibody (data not shown). Our HeLa cell coimmunoprecipitation results were also confirmed in Vero cells
(Fig. 1D). These experiments confirm our two-hybrid analysis and
further suggest that gK can bind to SPP in vitro.
It is possible that SPP could bind to other HSV-1 proteins and
thus our result would not be an interaction specific to gK. To
address this possibility we performed an additional IP with RS cells
that had been infected with 0.1 and 1.0 PFU/cell of HSV-1 strain
McKrae to probe for interaction of other viral proteins with SPP.
At 24 hr PI, infected cells were subjected to IP using SPP antibody
or total anti-HSV-1 antibody with mock serum as a control. This
anti-HSV-1 antibody recognizes many HSV-1 genes including all
major HSV-1 glycoproteins (i.e., gB, gC, gD) but not gK. The
results demonstrate that the total anti-HSV-1 antibody was able to
pull down many HSV-1 proteins, but not SPP (not shown). In
addition, the IP against SPP was not able to pull down any HSV-1

reacting proteins (not shown). Taken together these data
demonstrate that gK is the only HSV-1 gene that binds to SPP
in vitro.

Virus-expressed gK colocalizes with cellular SPP in vitro
To explore if gK and cellular SPP co-localize within the HSV-1
infected cells, HeLa, Vero and RS cells were infected with four
different HSV-1 recombinant viruses expressing V5 in-frame in
each of the four proposed domains of gK (Figure 2) [52]. These
recombinant viruses differ in the placement of the V5 tag; DI and
DIV have V5 on the luminal side while DII and DIII have the tag
on the cytoplasmic side (Figure 2G). Cells were infected with each
virus individually and IHC was performed using antibodies against
SPP and V5 as described in Materials and Methods. We detected
strong colocalization between V5-gK and endogenous SPP with
DI (Figure 2A), DII (Figure 2B) and DIII (Figure 2C) infected RS
cells. In contrast, HeLa and Vero cells had the strongest
colocalization with only DII and DIII viruses (Figures 2B and
2C), while we observed minor colocalization with the DIV virus in

Figure 1. Binding of gK to SPP in vitro. HeLa cells were transfected with c-myc-gK and HA-SPP plasmids at a 1:1 ratio for 48 hr. A) Expression and
pull-down of HA-SPP. Cellular lysates were incubated with anti-HA antibody bound to IgG beads and the resulting IP was subjected to Western blot
analysis with anti-HA antibody. Lane 1 shows untransfected HeLa cells and no HA-SPP band, while Lane 2 shows HA-SPP correctly
immunoprecipitating from transfected lysates. Lane 3 is protein size marker; B) Expression and pull-down of c-myc-gK. Cellular lysates were
incubated with anti-c-myc antibody bound to IgG beads and the resulting IP was subjected to Western blot analysis with anti-c-myc antibody. Lane 1
shows untransfected HeLa cells no c-myc-gK band, while Lane 2 shows c-myc-gK correctly immunoprecipitating from transfected lysates. Protein
sizes are indicated; and C/D) Co-immunoprecipitation of gK and SPP; C) HeLa Cells. Left panel: Cellular lysates were incubated with anti-HA antibody
bound to IgG beads and the resulting IP was subjected to Western blot analysis with anti-c-myc antibody. Lane 1 shows untransfected HeLa cells and
no gK band, while Lane 2 shows a successful pull-down of gK by anti-HA antibody. Right panel: Cellular lysates were incubated with anti-c-myc
antibody bound to IgG beads and the resulting IP was subjected to Western blot analysis with anti-HA antibody. Lane 1 shows untransfected HeLa
cells and no SPP band, while Lane 2 shows a successful pull-down of SPP by c-myc-gK. Protein sizes are indicated; D) Vero Cells. Left panel: Cellular
lysates were incubated with anti-HA antibody bound to IgG beads and the resulting IP was subjected to Western blot analysis with anti-c-myc
antibody. Lane 1 shows untransfected Vero cells and no gK band, while Lane 2 shows a successful pull-down of gK by anti-HA antibody. Right panel:
Cellular lysates were incubated with anti-c-myc antibody bound to IgG beads and the resulting IP was subjected to Western blot analysis with anti-HA
antibody. Lane 1 shows untransfected Vero cells and no SPP band, while Lane 2 shows a successful pull-down of SPP by c-myc-gK; E) HSV-1 infected
lysates subjected to IP with total HSV-1 serum followed by Western blot with total HSV-1 serum pulled down many proteins; F) HSV-1 Infected lysates
subjected to IP with total HSV-1 serum followed by Western blot with anti- SPP antibody did not pull down SPP; and G) HSV-1 infected lysates
subjected to IP with anti-SPP antibody followed by Western blot with total HSV-1 serum did not pull down any HSV-1 reacting proteins. Protein sizes
are indicated.
doi:10.1371/journal.pone.0085360.g001
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During the course of primary HSV-1 infection, gene expression
is synchronized in a cascade fashion. Thus, to determine if the
observed reduction in virus replication described above (Fig. 3A)
affected different classes of HSV-1 gene expression, we investigated the effect of SPP inhibition on HSV-1 tk, gB, and gK
expression at various times PI. RS cells were transfected with
shRNA plasmids followed by infection with HSV-1 strain McKrae
as described above. qRT-PCR was performed on total RNA
isolated from transfected-infected RS cells and real time analysis
performed. We detected significant reductions in expression of tk,
gB, and gK from 2.5 to 20 hr in cells treated with SPP shRNA
compared to cells treated with control scramble shRNA (Fig 3B).
These results indicate that tk and gB expression is also impaired
when SPP expression is blocked.
To confirm our titration and gene expression studies, we next
performed ICC against HSV-1 during treatment with shRNA
against SPP. RS cells were transfected and infected as above, and
at 24 hr PI subjected to ICC using anti-HSV-1-gC antibody. We
observed reduced staining for HSV-1 in SPP shRNA transfected
RS cells compared to scramble shRNA control (Fig. 3C). We also
observed a much more confluent monolayer in SPP shRNA
transfected and infected cells indicating reduced cellular lysis as
compared to SPP scramble shRNA transfected and infected cells.
To demonstrate that the reduction in viral replication and gene
expression was not due to higher apoptosis, we performed qRTPCR on RS cells transfected with SPP shRNA and infected with
HSV-1 and compared it to RS cells infected with HSV-1 alone

all cells lines tested (Figure 2D) and no colocalization in uninfected
control cells (Figure 2E). The gK-SPP interaction in all cell lines
infected with the 4 recombinant viruses are quantified and shown
in Figure 2F. These results validate our immunoprecipitation
results, since cellular SPP and HSV-1 expressed gK colocalize
within the cell.

SPP shRNA reduces HSV-1 replication in vitro
It has been previously shown that small interfering RNA
targeted to SPP reduced the production of infectious HCV
particles [55]. To explore the possibility that a reduction in SPP
production would effect HSV-1 replication, we constructed three
shRNA plasmids against SPP as described in Materials and
Methods. In a pilot experiment we tested the efficacy of these
shRNA against HSV-1 replication in vitro, and determined that
shRNA construct 11/12 was the most potent in reducing SPP
expression in Vero, RS, and HeLa cell lines (Figure S4). We next
tested this shRNA construct in RS cells to determine if SPP
knockdown had any effect on HSV-1 viral replication. Cells were
transfected with SPP shRNA, followed by infection with 0.1 PFU
of HSV-1 strain McKrae and HSV-1 titer was measured by
standard plaque assays. After 8 hr PI the SPP shRNA plasmid
began to significantly reduce viral replication in vitro when
compared to scrambled SPP shRNA plasmid (Fig 3A). Thus,
these results suggest that SPP is needed for efficient HSV-1
infectivity.

Figure 2. gK colocalizes with SPP in vitro. HeLa, Vero and RS cells were infected with 100 PFU/cell of each of four different recombinant HSV-1
expressing V5 tagged gK. Infection was allowed to proceed for 24 hr and slides were fixed, blocked and stained with mouse-anti-V5-FITC (green),
rabbit-anti-SPP-TRITC (red) and DAPI nuclear stain (blue). Photomicrographs are shown at 40X direct magnification and colocalization was visualized
as yellow. Panels: A) HeLa, Vero and RS cells were infected with gKV5DI; B) HeLa, Vero and RS cells were infected with gKV5DII; C) HeLa, Vero and RS
cells were infected with gKV5DIII; D) HeLa, Vero and RS cells were infected with gKV5DIV; E) Mock-infected HeLa, Vero and RS cells; F) Qualitative
assessment of colocalization of V5-gK and SPP in all cell lines; and G) V5-gK constructs showing the domain location of the V5 tag within the gK
protein. Arrows point to less obvious areas of colocalization. In each panel the top cell line is RS cells, the middle panel is HeLa cells and the bottom
panel is Vero cells.
doi:10.1371/journal.pone.0085360.g002
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Figure 3. Blocking HSV-1 replication in vitro by SPP shRNA. A) Viral Titer is reduced by SPP knockdown. RS cells were transfected for 24 hr
with either SPP shRNA or scramble shRNA and infected with 0.1 PFU/cell of HSV-1 strain McKrae. Titers were measured by standard plaque assays at
2.5, 5, 7.5, 10, 20 and 40 hr PI. Each point represents the mean 6 SEM from 3 independent experiments per time point; B) HSV-1 gene expression is
reduced by SPP knockdown. RS cells were transfected and infected as above. Transfected and infected cells were harvested 2, 4, 6, 8 and 20 hr PI,
RNA extracted and cDNA synthesized. Expression of tk, gB and gK were measured using qRT-PCR and each point represents the mean 6 SEM from 3
independent experiments; and C) HSV-1 protein expression is reduced by SPP knockdown. RS cells were transfected and infected as in A for 24 hr PI.
Cells were stained with anti-HSV-1-gC-FITC (green) and costained with DAPI (blue). Photomicrographs are shown at 10X magnification.
doi:10.1371/journal.pone.0085360.g003

and mock-treated control cells. We observed a significant
reduction in apoptosis in the presence of the SPP shRNA plasmid
compared to cells infected with HSV-1 alone (Figure S5). This
suggests that shRNA against SPP is not increasing cell death and is
actually protective of HSV-1 induced apoptosis. Taken together,
our RNA interference studies suggest that SPP is required for
efficient HSV-1 infectivity.
The effect of blocking SPP on intercellular transport properties
of the HSV-1 in the ER, lysosomes and endosomes was evaluated
in HSV-1 infected RS cells. RS cells were transfected with SPP
shRNA or scramble shRNA followed by infection with HSV-1.
Transfected-infected cells were monitored by immunofluorescence
or immunocytochemistry for the effect of SPP shRNA on
morphological properties of the ER, lysosomes and endosomes.
We detected significant differences between infected cells in
presence of SPP shRNA compared with cells transfected with
scramble shRNA and infected which were similar to uninfected
cells (Fig. 4A). Loss of SPP function resulted in the loss of discrete
punctate structures representing the endosomes around the
nuclear rim. RS cells were also infected with V5-tagged gK
PLOS ONE | www.plosone.org

recombinant virus gKV5DIII. Double staining for V5-gK and ER
is shown in Figure 4B, the arrow indicates a HSV-1 infected cell.
Our results show that gK also localizes in the ER (yellow), which
marks the primary site for a direct interaction between gK and
SPP.
With regards to endosomes we did not detect differences
between mock infected control and infected cells treated with SPP
shRNA or scramble shRNA (Fig. 5). However, we detected
striking difference in the lysosomes between mock infected control
and infected cells treated with SPP shRNA compared with cells
transfected with scramble shRNA and infected with HSV-1
(Fig. 5). In cells transfected with scramble shRNA and infected,
lysosomes were less visible upon infection and mostly located
around the nuclear rim and near the ER. Upon shRNA
downregulation of SPP the lysosomal population becomes very
similar to the uninfected cells. In this latter case the lysosomes were
uniformly distributed in the cytoplasm. Thus, our results suggest
that SPP regulates lysosomes and ER in response to HSV-1
infection.
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Figure 5. Effect of blockage of gK interaction with SPP on
intercellular transport properties of the HSV-1 in the lysosome
and endosome. RS cells were grown to confluency on chamber slides
and transfected with SPP shRNA or scramble shRNA followed by
infection with 1 PFU/cell of HSV-1. At 24 hr PI, slides were fixed, blocked
and stained with rabbit-anti-EEA1-TRITC (red) for endosome or rabbitanti-LAMP-TRITC (red) for lysosome. DAPI was used for nuclear staining
(blue). Photomicrographs are shown at 40X direct magnification.
doi:10.1371/journal.pone.0085360.g005

Figure 4. HSV-1 induces ER morphology changes which can be
blocked by SPP shRNA. A) RS cells were grown to confluency on
chamber slides and transfected with SPP shRNA or scramble shRNA
followed by infection with 1 PFU/cell of HSV-1. At 24 hr PI, slides were
fixed, blocked and stained with rabbit-anti-calnexin-TRITC (red) and
DAPI nuclear stain (blue). Photomicrographs are shown at 40X direct
magnification. HSV-1 infection induces condensation of ER while
treatment with SPP shRNA restores normal ER morphology. B) RS cells
were infected with gKV5DIII and stained for V5 (green) and calnexin
(red). Arrow indicates HSV-1 infected cell.
doi:10.1371/journal.pone.0085360.g004

(Fig. 6B, top panels) and Vero cells (Fig. 6C, bottom panel) are
shown. In both RS and Vero cells, the presence of D219A and
D265A reduced the amount of HSV-1 positive cells compared
with control groups (Fig. 6B and C). The positive cells per slide
were quantitated and indicate that there is approximately a 10 fold
reduction in HSV-1 signal in cells transfected with SPP dominant
negative mutants compared to untreated control cells (Fig 6D).
Collectively, these results confirm that reducing functional SPP
impairs HSV-1 replication.

SPP dominant negative mutants reduce HSV-1
replication in vitro
Dominant negative mutants are a powerful tool for studying
enzyme function as they complex with endogenous proteins,
inactivating the wild-type cellular proteins within the same cell.
The active site mutants, Asp219 (D219A) and Asp265 (D265A)
(constructs shown in Fig. S3), in which the catalytic aspartate
residues are mutated to alanine, have been shown to be dominant
negative inhibitors of endogenous SPP activity [1,56]. These
catalytic aspartates are highly conserved in all aspartic proteases
and their mutation destroys proper coordination of a water
molecule in the enzymatic active site, thereby destroying the acidbase reaction and rendering the mutants unable to catalyze their
substrate. Importantly, these mutations do not affect substrate
binding. To determine if the effect of these dominant negative
mutants would confirm our shRNA results, RS cells were
transfected with mammalian expression plasmids containing HAtagged dominant negative SPP plasmids, D219A or D265A,
followed by infection with 0.1 PFU of HSV-1 strain McKrae. The
kinetics of virus replication were quantitated by determining the
amount of infectious virus at various times PI using a standard
plaque assay as described in Materials and Methods. Replication
of HSV-1 in cells transfected with D219A or D265A was
significantly lower than the control group at various times PI
(Fig. 6A). In addition, D265A blocked virus replication more
efficiently then D219A (Fig. 6A). These results are consistent with
our shRNA results (Fig. 3, above) demonstrating that blocking SPP
catalytic ability, but not substrate binding, significantly reduces
HSV-1 virus replication in vitro.
To confirm our titration results with dominant negative
mutants, we transfected and infected monolayers of RS and Vero
cells as above and subjected them to ICC with anti-HSV-1-gC
antibody. Representative photomicrographs of infected RS cells
PLOS ONE | www.plosone.org

Discussion
Herein, we show for the first time that SPP is required for HSV1 infectivity and that SPP specifically binds to gK. Similar to this
study, it was previously shown that small interfering RNA targeted
to SPP reduced the production of infectious HCV particles [55].
In this study by using SPP dominant negative constructs and SPP
shRNA we have demonstrated that SPP is indeed essential for viral
replication. gK has been shown to interact with both HSV-1 gB
and UL20 [57,58]. However, our pull-down involving gK
expressing plasmid rules out the possibility that the gK-SPP
interaction is strictly dependent upon complexing with other viral
proteins. Furthermore, our pull-down of HSV-1 infected RS cells
using total HSV-1 antibody which does not recognize gK failed to
precipitate SPP and vice versa.
The role of SPP in the context of HSV-1 infection has yet to be
elucidated; however HSV-1 gK is a type III transmembrane
protein which contains an N terminal signal sequence utilized for
its insertion into the membrane [59,60]. HSV-1 gK has also been
shown to traffic through both the trans-Golgi network (TGN) [52]
and the rough endoplasmic reticulum (RER) [46]. To date, all
identified SPP substrates are signal peptides which span the ER in
a type II topology [2,61]. However, to our knowledge there is no
study showing that SPP cannot catabolize type III membrane
proteins. Type III membranes differ from type II in being multipass with the targeting signal sequence on the amino terminus.
The location of the signal sequence within gK is essential as both
deletion of the N terminus and N terminal cleavage via protease
reduce HSV-1 virion entry [62]. Recent work suggests that despite
7
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Figure 6. Blocking HSV-1 replication in vitro by SPP dominant negative mutants. A) Viral Titer is reduced by SPP dominant negatives. RS
cells were transfected for 24 hr with either dominant negative SPP D219A, SPP 265A or wild-type SPP and infected with 0.1 PFU/cell of HSV-1 strain
McKrae. Titers were measured by standard plaque assay 12, 24 and 48 hr PI. Each point represents the mean 6 SEM from 3 independent experiments
per time point; and B/C/D) HSV-1 protein expression is reduced by SPP knockdown. RS cells (B) and Vero cells (C) were transfected and infected as in
A. At 24 hr PI, cells were stained with anti-HSV-1-gC-FITC (green) and costained with DAPI (blue). Photomicrographs are shown at 10X magnification.
D) Quantification of HSV-1 positive cells from (B) and (C).
doi:10.1371/journal.pone.0085360.g006

neoplasia and neurodegeneration [70,71]. In addition, ER stress
has been demonstrated as causative in genetic and environmental
models of retinal degeneration [72]. Cells have evolved highly
conserved mechanisms to deal with ER stress through the
unfolded protein response (UPR) whereby functional protein
processing is restored or apoptosis is induced [71,73]. In fact,
HSV-1 has counter-evolved processes to sense ER stress and
downregulate the UPR to maintain ER homeostasis and prevent
apoptosis [74,75].
In line with the ER stress and the gK-induced collapse of the
Golgi apparatus [69], we have previously shown that a recombinant HSV-1 expressing two additional copies of gK induced severe
corneal scarring and dermatitis in different strains of mice [49].
Furthermore, we previously demonstrated that immunization of
mice with gK, but not with any of the other known HSV-1
glycoproteins, resulted in exacerbation of CS and herpetic
dermatitis following ocular HSV-1 infection [29,30]. As our
results clearly demonstrate the SPP and gK can bind and
colocalize with one another the possibility remains that the gK
interaction with SPP may be involved in the pathology of HSV-1
induced eye disease. Consequently, this gK-SPP interaction may
be considered as a specific therapeutic target for the prevention of
corneal infection in patients at risk and a reduction in the severity

SPP having a catalytic preference for Type II membrane proteins,
SPP is able to bind to many types of preproteins, signal peptides
and misfolded proteins [63]. It is in this context that SPP is
associated with quality control in the ER associated degradation
(ERAD) pathway [17,64]. SPP is thought to function as a
membrane protease liberating burdensome protein fragments
from the membrane [65,66]. The fate of these released peptides
can be degradation, however their role as signaling molecules is
emerging [67,68]. Under these circumstances the possibility exists
that SPP also serves to liberate bioactive fragments of viral proteins
including those capable of inducing gene expression. This scenario
could explain the negative effects on viral gene expression we
observed when SPP was reduced via shRNA.
It has also been shown that over-expression of gK in gKtransformed cells collapses the Golgi apparatus into the ER thus
inhibiting virion egress, glycoprotein transport, and virus-induced
cell fusion [69]. Similarly in this study we also observed
physiological signs of ER stress, such as ER aggregation, in cell
lines over-expressing gK. The possibility remains that the increase
in glycoprotein processing within the cell during the infectious
period damages the ER adding to the immunopathology caused
by the virus. The implications of ER stress are well documented in
human diseases such as diabetes mellitus atherosclerosis, hypoxia,

PLOS ONE | www.plosone.org
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and 58. gK construct was inserted into the BamHI site of plasmid
pcDNA3.1.
(PDF)

of the CS in patients who have established infections thereby
providing an effective treatment for those suffering from the
devastating effects of HSK.

Figure S3 HA-SPP constructs used for gK-SPP binding

Conclusion

and dominant negative transfection. The structure of the wt
SPP molecule of 43.5 kDa is shown with an in-frame insertion of
HA sequence and ER retention signal. Asp219 (D219A) and
Asp265 (D265A) are SPP dominant negative mutants in which
Asparagine (D) at aa positions 219 or 265 was mutated to Alanine
(A) and inserted into plasmid pcDNA3.1.
(PDF)

Glycoprotein K (gK) is a hydrophobic protein and is highly
conserved between HSV-1 and HSV-2. Studies using insertion/
deletion mutants have shown the importance of the gK in virion
morphogenesis and egress. We demonstrated previously that
immunization of mice with gK, but not with any of the other
HSV-1 glycoproteins, resulted in exacerbation of eye disease and
herpetic dermatitis following ocular HSV-1 infection independent
of mice or virus strain. We also have demonstrated that a
recombinant HSV-1 expressing two extra copies of gK exacerbated eye disease in both mice and rabbit, suggesting that gK overexpression is pathogenic. In this study we have shown for the first
time that: (1) HSV-1 gK binds to signal peptide peptidase (SPP);
and (2) ShRNA against SPP and SPP dominant negative mutants
reduced HSV-1 titers in vitro. Thus, blocking the interaction of gK
with SPP using SPP shRNA should be considered as a potential
alternative therapy in not only HSV-1, but other conditions
whereby SPP processing is integral to pathogenesis.

Figure S4 SPP knockdown by shRNA construct in
different cell lines. Vero, HeLa and RS cells were grown to
confluency and transfected with either SPP shRNA or scramble
shRNA. After 24 hr, RNA was isolated from each cell line and
qRT-PCR was performed as described in Materials and Methods.
SPP expression in each cell line was normalized to the scramble
SPP shRNA transfected control cells. Each point represents the
mean 6 SEM from 3 independent experiments.
(PDF)
Figure S5 Cell vitality in presence of SPP shRNA. RS cells
were transfected with SPP shRNA followed by infection with 0.1
PFU/cell of HSV-1 strain McKrae. Controls were uninfected cells
and cells infected with HSV-1 without SPP shRNA. Cells were
harvested 24 hr PI, stained with anti-Annexin-V antibody, and
FACS analyses was performed as described in Materials and
Methods. Shown is a graphical representation of the % of cells
undergoing apoptosis in each group.
(PDF)

Supporting Information
Figure S1 Results from bacerial-2-hybrid indicate SPP
interacts with gK. A) BLAST results from a representative
clone indicate strong consensus with all four isoforms of SPP. B)
Representative sequence alignment of an isolated clone and SPP
isoform 1.
(PDF)
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